DiaMedica Therapeutics Inc. (DMAC)
DMAC trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$7.82
-4.63% on the day
Market cap
$421.7M
Small cap
Revenue
No annual revenue filed since the period ending 2018-12-31
Net income
No annual revenue filed since the period ending 2018-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | DMAC on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2018 |
| SEC CIK | 0001401040 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | Z4 |
Financials
No annual revenue filed since the period ending 2018-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B2 | 424B2 | 2025-08-22 |
| Latest annual report FORM 10-K | 10-K | 2026-03-30 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-10 |
| Latest current report FORM 8-K | 8-K | 2026-08-10 |
| Latest proxy FORM DEFA14A | DEFA14A | 2026-04-01 |
Source: SEC EDGAR submissions feed, 427 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -3.4% |
| 1 month | +18.1% |
| 3 months | +8.2% |
| Year to date | -3.1% |
| 1 year | +9.3% |
| From 52-week high | -17.8% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| OVID | Ovid Therapeutics Inc. | $2.19 | -9.13% | $427.7M |
| PRTA | Prothena Corporation plc | $8.36 | -0.83% | $429.2M |
| ASMB | Assembly Biosciences Inc. | $20.34 | -10.67% | $414.1M |
| NGNE | Neurogene Inc. Common Stock | $21.56 | -11.78% | $431.4M |
| SPRY | ARS Pharmaceuticals Inc. | $4.05 | -3.11% | $402.8M |
| KMDA | Kamada Ltd. | $7.69 | -1.91% | $443.8M |
| CAPR | Capricor Therapeutics Inc. | $6.88 | -7.90% | $400.0M |
| AVIR | Atea Pharmaceuticals Inc. | $4.98 | -0.99% | $399.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier